CAS号:1310726-60-3
英文名:Upadacitinib
英文别名:ABT-494;(3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide;upatinib;Upadacitinb;Upadacitinib(ABT-494);ABT-494(Upadacitinib)freebase;benzyl(4S)-3-(N-(ethoxycarbonyl)-N-(5-tosyl-5H-pyrrolo[2,3-b]pyrazin-2-yl)glycyl)-4-ethylpyrrolidine-1-carboxylate;1-Pyrrolidinecarboxamide,3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-,(3S,4R)-;(3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide,Upadacitinib
中文名:乌帕替尼
中文别名:乌帕替尼;乌帕替尼无水物;氘2-乌帕替尼;乌帕替尼(无水);乌帕替尼游离碱基;乌帕替尼相关杂质;乌帕提尼(原料药);乌帕替尼(ABT-494);乌帕替尼半水合物(无水合物);UPADACITINIB抑制剂
分子式:C17H19F3N6O
分子量:380.37
乌帕替尼半水合物 Upadacitinib hemihydrate 2050057-56-0
N-[5-[(4-甲基苯基)磺酰基]-5H-吡咯并[2,3-B]吡嗪-2-基]氨基甲酸乙酯
Carbamic acid,N-[5-[(4-methylphenyl)sulfonyl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]-, ethyl este
1869118-24-0
(3R,4S)-3-(2-溴乙酰基)-4-乙基-1-吡咯烷羧酸苄酯
Benzyl(3R,4S)-3-(2-bromoacetyl)-4-ethylpyrrolidine-1-carboxylate
1428243-26-8
2，2，2-三氟乙基胺 trifluoroethylamine 753-90-2
(3R,4S)-苄基-3-(2-((乙氧羰基)(5-甲苯磺酰基-5H-吡咯并[2,3-B]吡嗪-2-基)氨基)乙酰基)-4-乙基吡咯烷-1-甲酸酯
1-Pyrrolidinecarboxylic acid, 3-[2-[(ethoxycarbonyl)[5-[(4-methylphenyl)sulfonyl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]amino]acetyl]-4-ethyl-, phenylmethyl ester, (3R,4S)-rel-
1869118-27-3
乌帕替尼N-2 Substituted pyrazine 2095311-51-4
(R)-9-[2-(二乙基膦酰甲氧基)丙基]腺嘌呤
(R)-9-[2-(DIETHYLPHOSPHONOMETHOXY)PROPYL]ADENINE
180587-75-1
乌帕替尼WPT-4 1-Pyrrolidinecarboxamide, 3-ethyl-4-[3-[(4-methylphenyl)sulfonyl]-3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl]-N-(2,2,2-trifluoroethyl)-, (3S,4R)-
2411540-30-0
8-((3S,4R)-4-乙基吡咯烷-3-基)-3-甲苯磺酰基-3H-咪唑并[1,2-A]吡咯并[2,3-E]吡嗪
8-((3R,4S)-4-ethylpyrrolidin-3-yl)-3-tosyl-3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazine
1428243-28-0
5-甲苯磺酰基-5H-吡咯并[2,3-B]吡嗪-2-胺基甲酸叔丁酯
tert-butyl 5-tosyl-5H-pyrrolo[2,3-b]pyrazin-2-ylcarbamate
1201187-44-1
(3S,4S)-benzyl 3-ethyl-4-(3-tosyl-3a,9a-dihydro-3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)pyrrolidine-1-carboxylate
1708997-42-5
2,2,2-三氟乙胺盐酸盐 2,2,2-trifluoroethanaminium chloride
373-88-6
4-(1H-吡唑-4-基)-7-((2-(三甲基硅烷基)乙氧基)-甲基)-7H-吡咯并[2,3-D]嘧啶 trimethyl-[2-[[4-(1H-pyrazol-4-yl)pyrrolo[2,3-d]pyrimidin-7-yl]methoxy]ethyl]silane
941685-27-4
2-[1-(乙基磺酰基)-3-氮杂环丁亚基]乙腈 2-(1-(Ethylsulfonyl)azetidin-3-ylidene)acetonitrile 1187595-85-2
3-[(三甲基硅基)乙炔基]-5-吡嗪-2-胺 5-Bromo-3-((trimethylsilyl)ethynyl)pyrazin-2-amine 875781-41-2
5-溴-4,7-二氮杂吲哚 5-Bromo-4,7-diazaindole 875781-43-4
关键字： JAK inhibitor; 痛风;替尼; GMP; DMF;
山东济坤生物制药有限公司成立于2022年，集化学原料药（中间体、新材料）、医疗器械的生产、内外贸销售于一体的制药企业，公司秉承“健康与美丽同行”的美好愿景，努力为客户提供高价值服务，持续助力健康美丽人生。